U.S. approves second Covid-19 booster for people 50 and older
The Food and Drug Administration on Tuesday authorized second Covid-19 boosters for people 50 years…
Category: Biotech
Osso VR lands $66 million to grow its virtual reality platform to train surgeons
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Pharmalittle: Pfizer employees balk at returning overpayments; Biogen stops work on another ALS drug
Rise and shine, everyone, another busy day is on the way. This morning is getting…
Covid-19 pandemic isn’t over for Black Americans, report warns
A searing report released Tuesday by the Black Coalition Against COVID details the immense toll…
CMMI’s Fowler on health policy’s ‘stubborn challenges,’ her personal ties to medicine
WASHINGTON — Liz Fowler’s career just came full circle: last March, she took charge of the…
Opinion: How to fix the two-tier U.S. health payment system
How the U.S. pays for health care is neither efficient nor fair. Despite spending an…
Afghan refugees, grappling with grief and trauma, face barriers to mental health care
WASHINGTON — For 17-year-old Salek Haseer, video games are an escape. They’re a way, however fleeting,…
STAT+: Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence
WASHINGTON — Health secretary Xavier Becerra is suddenly the target of a frenzied lobbying campaign…
‘A slow-moving glacier’: NIH’s sluggish and often opaque efforts to study long Covid draw patient, expert ire
WASHINGTON — The National Institutes of Health is fumbling its first efforts to study long…
STAT+: FDA review is critical of data on Amylyx ALS drug, but cites ‘regulatory flexibility’
Results from a single clinical trial of an experimental drug for ALS developed by Amylyx…
STAT+: Pharmalittle: Pharma showers cash on a rising U.S. Senate star; FDA restricts use of a Glaxo Covid treatment
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: HHS’s failure to address the health harms of climate crisis constitutes environmental and institutional racism
The 1964 Civil Rights Act prohibits discrimination against recipients of federal funding, including those covered…
Opinion: Unexpectedly united: The parallel plights of two communities 2,000 miles apart wracked by the pandemic
I constantly straddle two disparate worlds. One is in Boston, where I work for one…
STAT+: She was told ‘girls don’t do that.’ Now Margaret-Mary Wilson is a top executive at UnitedHealth Group
Long before she became a top executive at UnitedHealth Group, back in her native Nigeria,…
Denizens of ‘The Cave’ became changemakers and leaders. Here are some of its notable alumni
“All blind roads lead to Berkeley,” says Joshua Miele, a longtime resident of the Bay…
‘Where the bats hung out’: How a basement hideaway at UC Berkeley nurtured a generation of blind innovators
BERKELEY, Calif. — If, in the fall of 1987, you found yourself at the University…
.jpg)
Officials limit an antibody therapy, saying it’s ineffective against BA.2 variant of Omicron
U.S. health officials on Friday stopped the further deployment of the Covid-19 treatment sotrovimab to…
STAT+: Pharmalittle: Pharma hunts for a cure for long Covid; Texas AG deepens puberty-blocker probe into AbbVie and Endo
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Digital health: the latest iteration of medicine’s knowledge problem
When I did my residency in internal medicine and primary care a few years ago,…
Opinion: How we got herd immunity wrong
Herd immunity was always our greatest asset for protecting vulnerable people, but public health failed…
The internet’s funniest doctor is in on the joke
Will Flanary’s days are spent conducting eye exams and cataract surgeries at a private practice…
STAT+: Humility over hype: An AI leader at Google lays out a vision to transform medical care
From a high perch within Google, Greg Corrado is steering the development of artificial intelligence…
How physicians are capturing — or overlooking — virtual care’s value
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Listen: Helen Branswell on the evolving pandemic, plus the next FDA debate and the perks of being a CEO
Are Covid-19 vaccines a sustainable business? Was Aduhelm an aberration? And what comes after Omicron?…
STAT+: Despite competition, U.S. cancer drug prices rose even as they fell in Germany and Switzerland
Even as prices rose substantially in the U.S. over a recent 12-year period, a new…
STAT+: A hospital lobbying juggernaut makes an unlikely pivot into venture capital
The American Hospital Association is a lobbying powerhouse, championing the interests of its thousands of…
STAT+: As Google looks to get struggling health efforts back on track, it turns to a safe bet with search tools
At Google, it doesn’t get much more fundamental than Search. What better place for the…
STAT+: Sun Pharmaceuticals to pay $485 million to settle claims its Ranbaxy unit caused customers to overpay for generics
On the eve of a trial, Sun Pharmaceuticals has agreed to pay $485 million to…
Virtual Event: STAT x The 19th Represents: Gender and Health Outcomes
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: FDA rejects Lilly drug studied only in China; AstraZeneca suffers a setback with a key cancer drug
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Opinion: Private equity, health care, and profits: It’s time to protect patients
In his State of the Union address, President Biden expressed concern with the growing —…
.jpg)
NIH’s identity crisis: The pandemic and the search for a new leader leave the agency at a crossroads
WASHINGTON — Under the reign of Francis Collins, the National Institutes of Health was untouchable….
STAT+: Scientists test tetanus bacteria as a weapon to target pancreatic tumors
Pancreatic cancer has proved one of the most deadly forms of the disease, and the…
STAT+: Pharmalittle: Moderna asks FDA to OK Covid shot for kids under 6; big generic maker to close U.S. plant
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
Moderna to ask FDA to authorize Covid-19 vaccine in children 6 months to 6 years
Moderna announced Wednesday that it will ask the Food and Drug Administration to authorize its…
Opinion: Listen: Pharma companies market their drugs to young adults — so why don’t they include them in clinical trials?
Sneha Dave has been living with a chronic disease for 17 years — almost her…
Opinion: Google’s ongoing stem cell problem points to a larger issue with its search results on unproven therapies
Hey, Google: Remember that stem cell problem you tried to fix in 2019 by banning…
New Covid trial results may point toward better ways to study medicines
The battle against Covid-19 has been marked by false hope, as too many people embraced…
‘I fear the long-term effects’: Before his death, a nurse warned of the pandemic’s toll on health care workers
In early 2020, Michael Odell sensed that Covid-19 would hit hard. A young intensive care…
STAT+: TeamHealth hit with another lawsuit for alleged overbilling, this time from an employer
A Louisiana employer filed a class-action lawsuit against TeamHealth, alleging the private-equity-backed physician staffing firm…
STAT+: Aurobindo, major generic drug maker, will close a key U.S. production plant
Aurobindo Pharma, which is based in India and is one of the largest global producers…
With new ‘brain-reading’ research, a once-tarnished scientist seeks redemption
Niels Birbaumer, once a prominent neuroscientist at the University of Tübingen in Germany, fell hard…
With a $2.4 billion merger, a new company aims to transform kidney care
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Before Aduhelm, Billy Dunn was a superstar at the FDA
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
Opinion: Covid-19 vaccine policy should be made by public health experts, not company executives
In a March 13 interview with CBS, Albert Bourla, Pfizer’s CEO, said his company intended…
STAT+: Pharmalittle: FDA faces immense pressure over an ALS drug; former Biogen R&D chief seeks a reset at another biotech
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Al Sandrock, former top scientist at Biogen, named CEO at Voyager Therapeutics
Al Sandrock, the top scientist at Biogen who exited last year in a dispute over…
STAT+: Pfizer inks deal with UNICEF to supply Covid pill to poor countries, but advocates say it isn’t enough
As part of an effort to widen access to its Covid-19 pill, Pfizer has reached…
Opinion: The case for decriminalizing the street sale of buprenorphine
Isolation and anxiety caused by the Covid-19 pandemic has fueled an already out of control…
Opinion: Checklists work well for complicated health care problems. But they don’t work to solve complex ones, like pandemics
Federal public health officials did many good things in response to Covid-19, like investing in…